๐Ÿฅ VAERS Vaccine Data Browser

๐Ÿ”’ Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

๐Ÿ“– Help & Search Guide

Column Icons Legend

๐Ÿ’€ Death
๐Ÿฅ Hospitalized
๐Ÿš‘ Emergency Room
โ™ฟ Disability
โš ๏ธ Life Threatening

How to Search

๐Ÿ’ก Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "๐Ÿ“ฅ Export CSV" to download filtered data (max 10,000 records)

๐Ÿ’ก Frequently Asked Questions (FAQ)

What is this site?

๐Ÿฅ VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • โœ… Early warning system for potential safety signals
  • โœ… Open and transparent - publicly accessible
  • โœ… Accepts all reports regardless of likelihood of causation
  • โœ… Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • โš ๏ธ Reports are unverified - not investigated before publication
  • โš ๏ธ Cannot determine if vaccine caused the event
  • โš ๏ธ Underreporting - not all adverse events are reported
  • โš ๏ธ Overreporting - coincidental events may be reported
  • โš ๏ธ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

โš ๏ธ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
๐Ÿ”„ Reset ๐Ÿ“ฅ Export CSV
ID Age Sex State Date โ–ผ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative ๐Ÿ’€ ๐Ÿฅ ๐Ÿš‘ โ™ฟ โš ๏ธ
2868070 53 F CA 10/24/2025 COVID19
COVID19
COVID19
COVID19
 MODERNA
MODERNA
UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER

3052581
3052581
Chills, Headache, Injection site pain, Malaise, Pyrexia; Injection site pain, Py... Chills, Headache, Injection site pain, Malaise, Pyrexia; Injection site pain, Pyrexia; Chills, Headache, Injection site pain, Malaise, Pyrexia; Injection site pain, Pyrexia More
Fever of 102, pain at injection site, headache, malaise, chills Fever of 102, pain at injection site, headache, malaise, chills
2868076 75 F 10/24/2025 COVID19
 MODERNA
Dizziness, Illness, Nausea Dizziness, Illness, Nausea
get sick after it every time/getting sick; dizziness; nausea/general queasiness; This spontaneous ca... get sick after it every time/getting sick; dizziness; nausea/general queasiness; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (get sick after it every time/getting sick), DIZZINESS (dizziness) and NAUSEA (nausea/general queasiness) in a 75-year-old female patient who received mRNA-1273.251 (Spikevax LP.8.1 PFS) for COVID-19 prophylaxis. No Medical History information was reported. In October 2025, the patient received dose of mRNA-1273.251 (Spikevax LP.8.1 PFS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced ILLNESS (get sick after it every time/getting sick), DIZZINESS (dizziness) and NAUSEA (nausea/general queasiness). At the time of the report, ILLNESS (get sick after it every time/getting sick), DIZZINESS (dizziness) and NAUSEA (nausea/general queasiness) outcome was unknown. For mRNA-1273.251 (Spikevax LP.8.1 PFS) (Intramuscular use), the reporter did not provide any causality assessments. Concomitant medication was not provided. The patient had not taken any other vaccines in the past 4 weeks. It was reported that the patient's most recent vaccine was administered two days prior. And reported that the patient was over 65 years old, received a COVID-19 vaccine approximately every three months, typically before traveling. It was explained that she requested the vaccine by her selves and were not following any medical recommendation. Reporter added that she received multiple doses each year and experienced illness after each one. When asked whether the patient consistently received the Moderna vaccine, reporter responded that did not know exactly which one she was taking. It was noted that the patient experienced symptoms such as nausea, dizziness, and general queasiness symptoms described as matching those listed as common side effects and also remarked that she was generally less symptomatic. It was unknown if the patient experienced any additional symptoms or events. Treatment medication was not reported. This case was linked to US-MODERNATX, INC.-MOD-2025-790352, US-MODERNATX, INC.-MOD-2025-790353, US-MODERNATX, INC.-MOD-2025-790363, US-MODERNATX, INC.-MOD-2025-790362 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2025-790353:mother case spikevax nos case US-MODERNATX, INC.-MOD-2025-790352:husband case US-MODERNATX, INC.-MOD-2025-790362:SPIKEVAX NOS father case US-MODERNATX, INC.-MOD-2025-790363:Daughter case More
2868077 20 F 10/24/2025 FLU3
RSV
 SANOFI PASTEUR
PFIZER\WYETH
LL8391
Pruritus, Swelling, Urticaria; Pruritus, Swelling, Urticaria Pruritus, Swelling, Urticaria; Pruritus, Swelling, Urticaria
Pt had localized swelling with a palm size welt that had intermittent itching 12 hours after the vac... Pt had localized swelling with a palm size welt that had intermittent itching 12 hours after the vaccine. More
2868117 10/24/2025 VARZOS
 UNKNOWN MANUFACTURER
 UNK
Bell's palsy Bell's palsy
Bell's palsy; This serious case was reported by a consumer via interactive digital media and de... Bell's palsy; This serious case was reported by a consumer via interactive digital media and described the occurrence of bell's palsy in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced bell's palsy (Verbatim: Bell's palsy) (serious criteria GSK medically significant). The outcome of the bell's palsy was not reported. It was unknown if the reporter considered the bell's palsy to be related to Shingles vaccine. The company considered the bell's palsy to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 15-OCT-2025 This case was reported by a patient via interactive digital media. The patient was worried about taking any more vaccines and the Shingles vaccine in the past has caused the patient to have Bell's palsy and said don't want that to happen again who knows what else can happen to the patient; Sender's Comments: A case of Bell's palsy, unknown time after receiving Shingles vaccine, in a patient. Based on the available information, a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow up has not been received. More
2868118 F 10/24/2025 FLU3
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Wrong product administered Wrong product administered
Fluad was ordered but patient administered Flulaval due to nursing error; This non-serious case was ... Fluad was ordered but patient administered Flulaval due to nursing error; This non-serious case was reported by a nurse via sales rep and described the occurrence of wrong vaccine administered in a 67-year-old female patient who received Flu Seasonal TIV Quebec (FluLaval 2025-2026 season) for prophylaxis. Co-suspect products included Influenza vaccine inact sAg 3v (Fluad) for prophylaxis. On 02-OCT-2025, the patient received FluLaval 2025-2026 season. The patient did not receive Fluad. On 02-OCT-2025, an unknown time after receiving FluLaval 2025-2026 season, the patient experienced wrong vaccine administered (Verbatim: Fluad was ordered but patient administered Flulaval due to nursing error). The outcome of the wrong vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 09-OCT-2025 The reporter stated that, Fluad was ordered but patient administered Flulaval due to nursing error, no system errors identified. Research Nurse did not have access to barcode scanning. The reporter did not consent to follow up. The batch number was not provided, and we are unable to contact the reporter. More
2868123 44 F MO 10/24/2025 HEP
HEP
HEPA
 GLAXOSMITHKLINE BIOLOGICALS
UNKNOWN MANUFACTURER
GLAXOSMITHKLINE BIOLOGICALS
 9LK2G
UNK
3S54K
Extra dose administered, Underdose; Extra dose administered, Underdose; Extra do... Extra dose administered, Underdose; Extra dose administered, Underdose; Extra dose administered, Underdose More
Extra dose administered; underdose; Adult use of a child product; Extra doses; This non-serious case... Extra dose administered; underdose; Adult use of a child product; Extra doses; This non-serious case was reported by a other health professional via call center representative and described the occurrence of underdose in a 44-year-old female patient who received HAV (Havrix pediatric) (batch number 3S54K, expiry date 02-MAR-2025) for prophylaxis. Co-suspect products included HBV (Engerix B pediatric) (batch number 9LK2G, expiry date 14-SEP-2025) for prophylaxis and Hepatitis B vaccine for prophylaxis. Previously administered products included Havrix (The patient received a full series (2 doses) of Hepatitis A in 2007) and Engerix b (4 doses of Hepatitis B between 2002 and 2007). On 26-SEP-2024, the patient received the 3rd dose of Havrix pediatric and the 5th dose of Engerix B pediatric. On an unknown date, the patient received the 4th dose of Hepatitis B vaccine. On 26-SEP-2024, an unknown time after receiving Havrix pediatric and Engerix B pediatric and not applicable after receiving Hepatitis B vaccine, the patient experienced underdose (Verbatim: underdose), adult use of a child product (Verbatim: Adult use of a child product) and extra dose administered (Verbatim: Extra doses). On an unknown date, the patient experienced extra dose administered (Verbatim: Extra dose administered). The outcome of the underdose, adult use of a child product, extra dose administered and extra dose administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 25-SEP-2025 A patient over 18 year old but may have gotten a pediatric dose of hepatitis a (HAVRIX) and hepatitis b (ENGERIX-B) on 26-Sep-2024. Documentation was conflicting as the documented NDC and expiration dates did not match the lot number. For HAVRIX the documented NDC number was 58160-0825-43 and for ENGERIX B the documented NDC number was 58160-0820-43. The patient received a full series (2 doses) of Hepatitis A in 2007 (Brand unknown when asked) and 4 doses of Hepatitis B between 2002 and 2007 (brand unknown when asked). When asked for reason why patient received these doses in 2024, healthcare professional stated that the patient did call and there was a note in her chart that she was requesting a hep an and hep b vaccine and healthcare professional stated it could be for work which was typically the case when patients call requesting vaccines. More
2868124 IL 10/24/2025 DTAP
DTAPHEPBIP
DTAPIPV
FLU4
HEP
HEPA
HIBV
MENB
MNQ
RV1
TDAP
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
NOVARTIS VACCINES AND DIAGNOSTICS
NOVARTIS VACCINES AND DIAGNOSTICS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS










Product storage error; Product storage error; Product storage error; Product sto... Product storage error; Product storage error; Product storage error; Product storage error; Product storage error; Product storage error; Product storage error; Product storage error; Product storage error; Product storage error; Product storage error More
After the monthly excursion, the products were use and they bring again the same vaccines; This non... After the monthly excursion, the products were use and they bring again the same vaccines; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in an unspecified number of patients who received DTPa (Infanrix) for prophylaxis. Co-suspect products included DTPa-HBV-IPV (Pediarix) for prophylaxis, Rota (Rotarix liquid formulation) for prophylaxis, Hib (Hiberix) for prophylaxis, DTPa-IPV (Kinrix) for prophylaxis, Flu Seasonal QIV Quebec (FluLaval Quadrivalent) for prophylaxis, Men B NVS (Bexsero) for prophylaxis, Men ACWY-CRM NVS (Menveo) for prophylaxis, HAV (Havrix) for prophylaxis, HBV (Engerix B) for prophylaxis and DTPa (Reduced antigen) (Boostrix) for prophylaxis. On an unknown date, the patient received Infanrix, Pediarix, Rotarix liquid formulation, Hiberix, Kinrix, FluLaval Quadrivalent, Bexsero, Menveo, Havrix, Engerix B and Boostrix. On an unknown date, an unknown time after receiving Infanrix, Pediarix, Rotarix liquid formulation, Hiberix, Kinrix, FluLaval Quadrivalent, Bexsero, Menveo, Havrix, Engerix B and Boostrix, the patient experienced incorrect storage of drug (Verbatim: After the monthly excursion, the products were use and they bring again the same vaccines). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 25-SEP-2025 The healthcare professional mentioned that each excursion happened for the same products, but with different lot number. After the monthly excursion, the products were use and they bring again the same vaccines, but with different lot number. The vaccine administration facility was the same as primary reporter. During the call healthcare professional informed that after the monthly excursion, the products were use. The healthcare professional mentioned that they have no idea how many patients received the vaccines. In the adverse event report, they set all the vaccines, but it means that the patients received all of the vaccines. The batch number was not provided upon follow up with the reporter. More
2868126 NJ 10/24/2025 FLU3
 GLAXOSMITHKLINE BIOLOGICALS
Expired product administered Expired product administered
Flulaval administration of an expired dose; This non-serious case was reported by a pharmacist via ... Flulaval administration of an expired dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a specified number of patients who received Flu Seasonal TIV Quebec (FluLaval 2024-2025 season) (expiry date 30-JUN-2025) for prophylaxis. On 29-SEP-2025, the patients received FluLaval 2024-2025 season. On 29-SEP-2025, an unknown time after receiving FluLaval 2024-2025 season, the patients experienced expired vaccine used (Verbatim: Flulaval administration of an expired dose). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt date: 29-SEP-2025 A pharmacist contacted the medical team on behalf of a physician to report that, on that day, seven patients had received expired doses of the Flulaval vaccine. The pharmacist inquired about potential side effects, whether any issues should be expected, and whether the vaccine should be re-administered to the affected patients. The healthcare provider did not provide the lot number of the Flulaval vaccine. Additionally, the pharmacist did not have specific patient details but mentioned that all recipients were likely above 60 years of age. The batch number was not provided upon follow- up with the reporter. More
2868127 1 F LA 10/24/2025 DTAPIPV
 GLAXOSMITHKLINE BIOLOGICALS
 Y49B2
Product administered to patient of inappropriate age Product administered to patient of inappropriate age
Kinrix vaccine was administered to a 12-month-old patient; administration of Kinrix instead of Dapta... Kinrix vaccine was administered to a 12-month-old patient; administration of Kinrix instead of Daptacel/ DTaP; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 12-month-old female patient who received DTPa-IPV (Kinrix) (batch number Y49B2, expiry date 17-MAY-2026) for prophylaxis. Co-suspect products included Diphtheria vaccine toxoid, Pertussis vaccine acellular, Tetanus vaccine toxoid (Daptacel) for prophylaxis. On 12-SEP-2025, the patient received Kinrix. The patient did not receive Daptacel. On 12-SEP-2025, an unknown time after receiving Kinrixl, the patient experienced inappropriate age at vaccine administration (Verbatim: Kinrix vaccine was administered to a 12-month-old patient) and wrong vaccine administered (Verbatim: administration of Kinrix instead of Daptacel/ DTaP). The outcome of the inappropriate age at vaccine administration and wrong vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 30-SEP-2025 The patient was administration of Kinrix instead of Daptacel/ DTaP which led to wrong vaccine administered. The batch number was not provided upon follow- up with the reporter. More
2868128 12 F GA 10/24/2025 FLU3
 GLAXOSMITHKLINE BIOLOGICALS
 33CM4
Underdose Underdose
gave half of the vaccine dose; This non-serious case was reported by a other health professional via... gave half of the vaccine dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of underdose in a 12-year-old female patient who received Flu Seasonal TIV Quebec (FluLaval 2025-2026 season) (batch number 33CM4, expiry date 28-JUN-2026) for prophylaxis. On 22-SEP-2025, the patient received FluLaval 2025-2026 season. On 22-SEP-2025, an unknown time after receiving FluLaval 2025-2026 season, the patient experienced underdose (Verbatim: gave half of the vaccine dose). The outcome of the underdose was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 30-Sep-2025 Medical Assistant called to ask for advice, since they gave half of the vaccine dose. Do they have to wait 30 days to give a full dose? More
2868129 F FL 10/24/2025 HEPAB
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Incomplete course of vaccination Incomplete course of vaccination
patient already had the one dose and second dose, but she missed the third dose; This non-serious ca... patient already had the one dose and second dose, but she missed the third dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a female patient who did not receive HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (2nd dose received on an 09th September 2021 with batch number DK23D and expiry date of 08th February 2022) and Twinrix (received 1st dose on an unknown date). On an unknown date, the patient did not receive the 3rd dose of Twinrix. The patient experienced incomplete course of vaccination (Verbatim: patient already had the one dose and second dose, but she missed the third dose). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 30-SEP-2025 The patient had previously received the first and second doses of the vaccine but missed the third dose. As of now, four years have passed since the second dose. The nurse inquired whether the patient could still receive the booster dose or if the vaccination series needed to be restarted. The batch number was not provided and a request for this information has been made. More
2868130 3 M OR 10/24/2025 FLU3
 GLAXOSMITHKLINE BIOLOGICALS
 F4A7R
Inappropriate schedule of product administration Inappropriate schedule of product administration
first dose was administered on 23rd September 2025, and 2nd dose was administered on 29 September 20... first dose was administered on 23rd September 2025, and 2nd dose was administered on 29 September 2025; This non-serious case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a 3-year-old male patient who received Flu Seasonal TIV Quebec (FluLaval 2025-2026 season) (batch number F4A7R, expiry date 06-JUN-2026) for prophylaxis. Concomitant products included Influenza vaccine inact split 3v (Flulaval). On 29-SEP-2025, the patient received the 2nd dose of FluLaval 2025-2026 season. On 29-SEP-2025, an unknown time after receiving FluLaval 2025-2026 season, the patient experienced drug dose administration interval too short (Verbatim: first dose was administered on 23rd September 2025, and 2nd dose was administered on 29 September 2025). The outcome of the drug dose administration interval too short was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt date: 30-SEP-2025 Reporter reported someone else gave a child an early 2nd dose of FluLaval. The child had never been vaccinated and was due for 2 doses. The first dose was administered on 23rd September 2025, and 2nd dose was administered on 29th September 2025.; Sender's Comments: US-GSK-US2025125441:Same reporter/Diffrent patient More
2868131 69 NJ 10/24/2025 FLU3
 GLAXOSMITHKLINE BIOLOGICALS
Extra dose administered Extra dose administered
Maladministration FLULAVAL two doses on an adult patient; This non-serious case was reported by a ot... Maladministration FLULAVAL two doses on an adult patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 69-year-old patient who received Flu Seasonal TIV Quebec (FluLaval 2025-2026 season) for prophylaxis. Concomitant products included Influenza vaccine inact split 3v (Flulaval). On 03-OCT-2025, the patient received the 2nd dose of FluLaval 2025-2026 season. On 03-OCT-2025, an unknown time after receiving FluLaval 2025-2026 season, the patient experienced extra dose administered (Verbatim: Maladministration FLULAVAL two doses on an adult patient). The outcome of the extra dose administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 03-OCT-2025 Medical Assistant called asking for advice, since a patient was administered two doses of the Flulaval vaccine. The nurses were following the high dose flu vaccination schedule due to the patients age (and also they only carry Flulaval there). Medical Assistant needs guidance on this specific patient๏ฟฝs vaccination. More
2868132 F AZ 10/24/2025 FLUX
 UNKNOWN MANUFACTURER
 UNK
Condition aggravated, Eosinophilic granulomatosis with polyangiitis Condition aggravated, Eosinophilic granulomatosis with polyangiitis
Patient got eosinophils /EGPA reacted; Patient got eosinophils /EGPA reacted; eosinophils due to the... Patient got eosinophils /EGPA reacted; Patient got eosinophils /EGPA reacted; eosinophils due to the flu vaccine entering patient's system; This serious case was reported by a pharmacist via call center representative and described the occurrence of eosinophilic granulomatosis with polyangiitis in a female patient who received mepolizumab (Nucala) for eosinophilic granulomatosis with polyangiitis. Co-suspect products included Flu unspecified (Flu vaccine) for product used for unknown indication. Concurrent medical conditions included eosinophilic granulomatosis with polyangiitis. On an unknown date, the patient started Nucala and Flu vaccine. On an unknown date, an unknown time after receiving Nucala and Flu vaccine, the patient experienced eosinophilic granulomatosis with polyangiitis (Verbatim: Patient got eosinophils /EGPA reacted) (serious criteria hospitalization and GSK medically significant), condition aggravated (Verbatim: Patient got eosinophils /EGPA reacted) (serious criteria hospitalization) and vaccination adverse reaction (Verbatim: eosinophils due to the flu vaccine entering patient's system) (serious criteria hospitalization). The action taken with Nucala and Flu vaccine was unknown. The outcome of the eosinophilic granulomatosis with polyangiitis, condition aggravated and vaccination adverse reaction were not reported. It was unknown if the reporter considered the eosinophilic granulomatosis with polyangiitis, condition aggravated and vaccination adverse reaction to be related to Nucala. The reporter considered the eosinophilic granulomatosis with polyangiitis, condition aggravated and vaccination adverse reaction to be related to Flu vaccine. The company considered the eosinophilic granulomatosis with polyangiitis, condition aggravated and vaccination adverse reaction to be unrelated to Nucala and Flu vaccine. GSK receipt date: 07-OCT-2025 Pharmacist called and mentioned for patient on Nucala with EGPA indication. Patient got a flu shot several years ago and patient had to go to the hospital because patient's EGPA reacted and patient got eosinophils due to the flu vaccine entering patient's system. Did not consent to follow-up. Call Notes: No clarification on which flu vaccine was given. No consent to follow-up asked, decision to report was made after the call ended.; Sender's Comments: The company has assessed that it is unlikely that Eosinophilic granulomatosis with polyangiitis, Condition aggravated and Immunisation reaction were caused by the Nucala drug. Based on the available information a possible causality that the event(s) was caused by the product cannot be ascertained. Consent for further follow up has not been received. A case of Eosinophilic granulomatosis with polyangiitis, Condition aggravated and Immunisation reaction, an unknown time after receiving a dose of Flu vaccine, in a female subject. Based on the available information a possible causality that the event(s) was caused by the GSK product cannot be ascertained. Consent for further follow up has not been received. More
โœ“
2868134 70 F MN 10/24/2025 HEPA
 GLAXOSMITHKLINE BIOLOGICALS
 3J9G4
Expired product administered Expired product administered
Expired Product Used - Maladministration of an expired dose; This non-serious case was reported by a... Expired Product Used - Maladministration of an expired dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 70-year-old female patient who received HAV (Havrix) (batch number 3J9G4, expiry date 30-AUG-2025) for prophylaxis. On 08-OCT-2025, the patient received Havrix. On 08-OCT-2025, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: Expired Product Used - Maladministration of an expired dose). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. More
2868135 F FL 10/24/2025 COVID19
 MODERNA
Limb discomfort, Lymphadenitis Limb discomfort, Lymphadenitis
Arm it is tender on touching; lymphatic tract of whole left arm from the axilla all the way to the w... Arm it is tender on touching; lymphatic tract of whole left arm from the axilla all the way to the wrist/the axillary lymph nodes began aching, and then it's just been progressing down arm even through today/swelling of axillary glands, lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Arm it is tender on touching) and LYMPHADENITIS (lymphatic tract of whole left arm from the axilla all the way to the wrist/the axillary lymph nodes began aching, and then it's just been progressing down arm even through today/swelling of axillary glands, lymph nodes) in a female patient of an unknown age who received mRNA-1273.251 (Spikevax LP.8.1 PFS) for COVID-19 prophylaxis. No Medical History information was reported. On 13-Oct-2025, the patient received dose of mRNA-1273.251 (Spikevax LP.8.1 PFS) (unknown route) 1 dosage form. In October 2025, the patient experienced LIMB DISCOMFORT (Arm it is tender on touching) and LYMPHADENITIS (lymphatic tract of whole left arm from the axilla all the way to the wrist/the axillary lymph nodes began aching, and then it's just been progressing down arm even through today/swelling of axillary glands, lymph nodes). At the time of the report, LIMB DISCOMFORT (Arm it is tender on touching) and LYMPHADENITIS (lymphatic tract of whole left arm from the axilla all the way to the wrist/the axillary lymph nodes began aching, and then it's just been progressing down arm even through today/swelling of axillary glands, lymph nodes) had not resolved. Concomitant medications were not reported. The reporter experienced the pain along the lymphatic tract of whole left arm from the axilla all the way to the wrist. The axillary lymph nodes began aching and then it was just been progressing down arm. it was pain when stretch out arm and it was tender on touching. There was swelling of axillary glands and lymph nodes. It was reported that patient had exactly the same symptoms as of reporter. Patient was immunized on Monday. Treatment information was not reported. This case was linked to US-MODERNATX, INC.-MOD-2025-790344 (E2B Linked Report).; Reporter's Comments: The benefit -risk relationship of product is not affected by this report.; Sender's Comments: US-MODERNATX, INC.-MOD-2025-790344:Reporter case More
2868136 77 M 10/24/2025 COVID19
 MODERNA
Dizziness, Illness, Nausea Dizziness, Illness, Nausea
going to the doctor again because he is sick; dizziness; nausea/general queasiness; This spontaneous... going to the doctor again because he is sick; dizziness; nausea/general queasiness; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (going to the doctor again because he is sick), DIZZINESS (dizziness) and NAUSEA (nausea/general queasiness) in a 77-year-old male patient who received mRNA-1273.251 (Spikevax LP.8.1 PFS) for COVID-19 prophylaxis. No Medical History information was reported. On 14-Oct-2025, the patient received dose of mRNA-1273.251 (Spikevax LP.8.1 PFS) (unknown route) 1 dosage form. In October 2025, the patient experienced ILLNESS (going to the doctor again because he is sick), DIZZINESS (dizziness) and NAUSEA (nausea/general queasiness). At the time of the report, ILLNESS (going to the doctor again because he is sick) had not resolved and DIZZINESS (dizziness) and NAUSEA (nausea/general queasiness) outcome was unknown. Concomitant medication included blood thinners. The patient had not taken any vaccines in the past 4 weeks. The patient had most recent vaccine was 2 days ago. The patient got a COVID vaccine every 3 months, he asks for it and get it every time the patient and his wife travel. The patient got numerous vaccines a year and they get sick after it every time. They get it because they want to get it, they were not being recommended by anyone, and they were just continuing to take it. They get the symptoms what was listed on there - the nausea, dizziness, general queasiness, it felt like they were getting sick. The patient was going to the doctor again because he was sick. The wife had less symptoms, in general she was less symptomatic, not to the severity husband has ever had. It was unknown if the patient experienced any additional symptoms/events. No treatment medication was reported. This case was linked to US-MODERNATX, INC.-MOD-2025-790351 (E2B Linked Report). This case was linked to MOD-2025-790362 (Patient Link).; Sender's Comments: US-MODERNATX, INC.-MOD-2025-790351:Wife's case More
2868137 F 10/24/2025 COVID19
 MODERNA
Illness, Influenza like illness Illness, Influenza like illness
has gotten sick every time she has had one as well; She feels like she gets the flu, "flu-like ... has gotten sick every time she has had one as well; She feels like she gets the flu, "flu-like symptoms", and it hits immediately, within 12-24 hours and lasts about 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (She feels like she gets the flu, "flu-like symptoms", and it hits immediately, within 12-24 hours and lasts about 24 hours) and ILLNESS (has gotten sick every time she has had one as well) in an adult female patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. In 2024, the patient received fourth dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, received second dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) dosage was changed to 1 dosage form and first dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) dosage was changed to 1 dosage form. In 2024, the patient experienced INFLUENZA LIKE ILLNESS (She feels like she gets the flu, "flu-like symptoms", and it hits immediately, within 12-24 hours and lasts about 24 hours). On an unknown date, the patient experienced ILLNESS (has gotten sick every time she has had one as well). In 2024, INFLUENZA LIKE ILLNESS (She feels like she gets the flu, "flu-like symptoms", and it hits immediately, within 12-24 hours and lasts about 24 hours) had resolved. At the time of the report, ILLNESS (has gotten sick every time she has had one as well) outcome was unknown. No concomitant medication was reported. It was stated she never got vaccines close together so no vaccines within the 4 weeks prior to her last vaccine. It was stated that patient most recent vaccine was a year ago. It was stated that patient has gotten sick every time she had one as well. Patient felt like she got the flu, "flu-like symptoms", and it hits immediately, within 12-24 hours and lasted about 24 hours. It was stated patient had 4 vaccines. It was unknown if the patient experienced any additional symptoms/events. No treatment information was reported. This case was linked to US-MODERNATX, INC.-MOD-2025-790351 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2025-790351:Mother Spikevax nos case More
2868138 F 10/24/2025 COVID19
 MODERNA
Peripheral swelling, Vaccination site mass, Vaccination site reaction Peripheral swelling, Vaccination site mass, Vaccination site reaction
arm was swollen; Covid arm; huge lump/just this one area where patient got the injection; This spont... arm was swollen; Covid arm; huge lump/just this one area where patient got the injection; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm was swollen), VACCINATION SITE REACTION (Covid arm) and VACCINATION SITE MASS (huge lump/just this one area where patient got the injection) in a female patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (arm was swollen), VACCINATION SITE REACTION (Covid arm) and VACCINATION SITE MASS (huge lump/just this one area where patient got the injection). At the time of the report, PERIPHERAL SWELLING (arm was swollen), VACCINATION SITE REACTION (Covid arm) and VACCINATION SITE MASS (huge lump/just this one area where patient got the injection) outcome was unknown. No concomitant medication was reported. Patient had a similar reaction with prior Moderna Covid-19 vaccines. Information in regard to the prior Moderna Covid-19 vaccines were not provided. It was unknown if the patient experienced any additional symptoms/events. No treatment medication was reported. Causality was not reported. This case was linked to MOD-2025-790380 (Patient Link). More
2868139 58 F 10/24/2025 COVID19
 MODERNA
Post-acute COVID-19 syndrome Post-acute COVID-19 syndrome
long COVID; This spontaneous case was reported by a consumer and describes the occurrence of POST-AC... long COVID; This spontaneous case was reported by a consumer and describes the occurrence of POST-ACUTE COVID-19 SYNDROME (long COVID) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. The patient's past medical history included Asthma (childhood asthma exacerbated by the flu/High risk severe Asthma) and Flu (childhood asthma exacerbated by the flu). In 2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2025, the patient experienced POST-ACUTE COVID-19 SYNDROME (long COVID). At the time of the report, POST-ACUTE COVID-19 SYNDROME (long COVID) outcome was unknown. No concomitant medications were reported. The patient stated that she had nearly died from COVID this past month as she was 58 years old at high risk with asthma. The patient suffered from debilitating long COVID, which prevented her from working. The patient equated COVID to death row with an alligator and stated that it went through everything, her throat and her chest. She stated it had made a marked difference; she had been crawling on all fours, thought she was going to die from fatigue and experienced breathing issues, but now she was walking around, also stated that her throat felt a little bit better. The patient received mNEXSPIKE vaccine on 15-Oct-2025. No treatment medications were reported. This case was linked to US-MODERNATX, INC.-MOD-2025-790418 (E2B Linked Report). This case was linked to MOD-2025-790336 (Patient Link).; Sender's Comments: US-MODERNATX, INC.-MOD-2025-790418:Daughter case More
2868140 74 F 10/24/2025 COVID19
 MODERNA
Chills, Pyrexia Chills, Pyrexia
chills; FEVER; This spontaneous case was reported by a consumer and describes the occurrence of CHIL... chills; FEVER; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and PYREXIA (FEVER) in a 74-year-old female patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills) and PYREXIA (FEVER). At the time of the report, CHILLS (chills) and PYREXIA (FEVER) outcome was unknown. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Unknown) was unknown. Concomitant medication was not reported. Treatment medication was not reported. This case was linked to US-MODERNATX, INC.-MOD-2021-320123 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-320123:Master case More
2868141 40 M 10/24/2025 COVID19
 MODERNA
Chills, Pyrexia Chills, Pyrexia
Chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of CHIL... Chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and PYREXIA (fever) in a 5-decade-old male patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills) and PYREXIA (fever). At the time of the report, CHILLS (Chills) and PYREXIA (fever) outcome was unknown. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Unknown) was unknown. Concomitant medication was not reported. Treatment medication was not reported. This case was linked to US-MODERNATX, INC.-MOD-2021-320123 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-320123:One male, 4 early 40s More
2868144 64 F SC 10/24/2025 FLU3
 SEQIRUS, INC.
 407266
Incorrect dose administered, No adverse event Incorrect dose administered, No adverse event
Fluad High dose was given to a pt that is 64. No adverse reactions noted. Fluad High dose was given to a pt that is 64. No adverse reactions noted.
2868145 1.25 M ME 10/24/2025 FLU3
HEPA
 SANOFI PASTEUR
GLAXOSMITHKLINE BIOLOGICALS
 UT8779KA
42DM9
Injection site urticaria, Urticaria; Injection site urticaria, Urticaria Injection site urticaria, Urticaria; Injection site urticaria, Urticaria
Pt developed hives on 10/22/25, approx 25hrs after vaccines given. Hives started on left leg near in... Pt developed hives on 10/22/25, approx 25hrs after vaccines given. Hives started on left leg near inhection site and traveled to the other leg, in the diaper area and some on the left arm too. Hives were large and continued to spread so pt's mother called on 10/23/25 to report this to PCP who reviewed images of the hives and confirmed this could be an adverse reaction given no other illness or known new exposures at this time. More
2868146 10 M MI 10/24/2025 FLU3
 SANOFI PASTEUR
 U8855DA
Incorrect dose administered Incorrect dose administered
High dose influenza vaccine given instead of regular influenza vaccine High dose influenza vaccine given instead of regular influenza vaccine
2868147 2 M MI 10/24/2025 FLU3
 SANOFI PASTEUR
 U8881CA
Injection site erythema, Injection site swelling, Weight bearing difficulty Injection site erythema, Injection site swelling, Weight bearing difficulty
Significant redness and swelling to limb in which vaccine was administered. No cellulitis or myositi... Significant redness and swelling to limb in which vaccine was administered. No cellulitis or myositis. Transient difficulty with weight bearing. Gradually improved with appropriate use of NSAIDs and rest. More
2868148 16 M AR 10/24/2025 MNQ
 NOVARTIS VACCINES AND DIAGNOSTICS
 amv079a
Blood test, Hypoaesthesia, Paraplegia, Scan, Tremor Blood test, Hypoaesthesia, Paraplegia, Scan, Tremor
Patient had tremoring in right arm 3 hours after vaccination in left arm. On 10/1/25 he had numbness... Patient had tremoring in right arm 3 hours after vaccination in left arm. On 10/1/25 he had numbness in his right leg. On 10/2/25, his right leg was paralyzed. He has been seen at Hospital on two occasions since symptoms started, and is now set up to see a separate neurologist. As of 10/18/25, the patient is paralyzed from waist down per father. More
โœ“ โœ“
2868149 39 F PA 10/24/2025 UNK
 UNKNOWN MANUFACTURER
Eye swelling, Swelling face Eye swelling, Swelling face
Swollen eyes and face Swollen eyes and face
2868151 89 M IA 10/24/2025 COVID19
 MODERNA
Death Death
Expired on 10/24/2025 Expired on 10/24/2025
โœ“
2868153 45 M MN 10/24/2025 FLU3
 SANOFI PASTEUR
Arthralgia, Impaired driving ability, Limb injury, Loss of personal independence... Arthralgia, Impaired driving ability, Limb injury, Loss of personal independence in daily activities, Sleep disorder More
Left shoulder injury. Patient noted that the injection seemed relatively high up on the shoulder. ... Left shoulder injury. Patient noted that the injection seemed relatively high up on the shoulder. Shoulder pain was noted to start the evening of the vaccine. Pain has not subsided since receiving the vaccine. Pain is notably worse in the evening, and present with daily activities like driving, laundry, and sleeping. More
2868155 21 F MN 10/24/2025 UNK
 UNKNOWN MANUFACTURER
 7FY52
Blister, Rash, Urticaria Blister, Rash, Urticaria
I received the flu vaccine around 9:45 am on 10/23/25 and around 4 PM I noticed blisters/bumps on my... I received the flu vaccine around 9:45 am on 10/23/25 and around 4 PM I noticed blisters/bumps on my right earlobe. I came home from work around 12 am and noticed my upper back was covered in hives. No shortness of breath, nausea, vomiting, etc. More
2868156 6 M DC 10/24/2025 FLU3
 SANOFI PASTEUR
Induration, Pain in extremity, Peripheral swelling, Pruritus, Skin warm Induration, Pain in extremity, Peripheral swelling, Pruritus, Skin warm
Arm swollen, hard, hot, itchy painful Arm swollen, hard, hot, itchy painful
2868157 84 M IN 10/24/2025 COVID19
FLU3
 PFIZER\BIONTECH
SANOFI PASTEUR
 NA0589
U8855AA
Neck pain, Pain in extremity; Neck pain, Pain in extremity Neck pain, Pain in extremity; Neck pain, Pain in extremity
Patient's wife called to report patient was seen in the ER today with suspected hematoma relate... Patient's wife called to report patient was seen in the ER today with suspected hematoma related to vaccination on 10/7/25. First signs were pain in left arm and neck. Pain worsened with time. Patient's wife reports the ER provider believed the condition was due to vaccination while patient was taking warfarin and clopidogrel. More
2868158 24 F ND 10/24/2025 FLU3
 GLAXOSMITHKLINE BIOLOGICALS
 N9cs2
Arthralgia, Immediate post-injection reaction, Mobility decreased, Muscular weak... Arthralgia, Immediate post-injection reaction, Mobility decreased, Muscular weakness, Sleep disorder More
Patient reports she develops immediate right shoulder pain after vaccine administration. Patient rep... Patient reports she develops immediate right shoulder pain after vaccine administration. Patient reports "something did not feel right". Reports it didn't feel like typical muscle pain she has had with prior vaccine administration. Since the vaccine administration, she has been having right shoulder pain that is worsening. The pain is an ache, worse in the morning and has been waking her up the past couple of nights. Reports feeling weakness into her right upper extremity. Has been having trouble lifting things such as her lunch box. Pain is intermittent. At the time of this report, it has been 16 days since vaccine administration. More
2868162 83 M FL 10/24/2025 COVID19
 PFIZER\BIONTECH
 NA4452
Wrong product administered Wrong product administered
Patient's daughter signed him up to receive Non mRNA vaccine, but rx was mistyped and patient w... Patient's daughter signed him up to receive Non mRNA vaccine, but rx was mistyped and patient was given mRNA vaccine More
2868164 83 F TN 10/24/2025 FLU3
RSV
 SANOFI PASTEUR
GLAXOSMITHKLINE BIOLOGICALS

Extra dose administered; Extra dose administered Extra dose administered; Extra dose administered
Patient received a second dose of Arexvy on 10/22/25 after already receiving a dose on 10/25/24 Patient received a second dose of Arexvy on 10/22/25 after already receiving a dose on 10/25/24
2868165 67 F WI 10/24/2025 COVID19
 PFIZER\BIONTECH
Ear discomfort Ear discomfort
Ear echoing, fullness on right side Ear echoing, fullness on right side
2868166 59 F NC 10/24/2025 FLU3
 SEQIRUS, INC.
 406991
Injection site erythema, Injection site pain, Injection site swelling Injection site erythema, Injection site pain, Injection site swelling
redness at the injection site noticed at time of evening shower . Progressive swelling/redness to a... redness at the injection site noticed at time of evening shower . Progressive swelling/redness to a measurement of 6cmx6cm, tenderness. No flu like symptoms. have had flu shots since mid 1980's, no similar reactions More
2868167 9 F MN 10/24/2025 COVID19
FLU3
 MODERNA
SEQIRUS, INC.
 3052859
410514
Malaise; Malaise Malaise; Malaise
patient stated she was not feeling well. was lowered to the floor. she received juice then was fine patient stated she was not feeling well. was lowered to the floor. she received juice then was fine
2868168 84 F MI 10/24/2025 COVID19
FLU3
 PFIZER\BIONTECH
SEQIRUS, INC.
 MY9548
407265
Extra dose administered; Extra dose administered Extra dose administered; Extra dose administered
Patient's family was asked at appt if she would like a Covid and Flu vaccine, they agreed. Her ... Patient's family was asked at appt if she would like a Covid and Flu vaccine, they agreed. Her chart was checked prior because we receive updates directly from immune registry. It did not show that she was given these vaccines for 2025-2026 season. Received both vaccines. Received a call after stating that she received both of these on 10/16/25 at clinic. Checked her chart and it was updated with the vaccines from 10/16/25. Discussed with our software person and they ran an audit and there was a 10 min lag from where the vaccines where given to when the vaccines from immune registry were added to her chart. More
2868169 66 F GA 10/24/2025 FLU3
 SANOFI PASTEUR
 UT8781DA
Injection site erythema, Injection site pain, Injection site pruritus Injection site erythema, Injection site pain, Injection site pruritus
Redness around injection site, stinging, burning, itching, hurting, intermitted sharp stingy pains Redness around injection site, stinging, burning, itching, hurting, intermitted sharp stingy pains
2868171 71 F FL 10/24/2025 FLU3
RSV
 SANOFI PASTEUR
GLAXOSMITHKLINE BIOLOGICALS
 u8859da
f4ac3
No adverse event; No adverse event No adverse event; No adverse event
no symptoms to report at this time no symptoms to report at this time
2868172 92 F NJ 10/24/2025 FLU3
 SANOFI PASTEUR
 U8823BA
Headache, Imaging procedure Headache, Imaging procedure
PT reported onset of headache on the morning of Oct 15, 2025 PT reported onset of headache on the morning of Oct 15, 2025
2868173 96 F LA 10/24/2025 COVID19
 PFIZER\BIONTECH
 NA0587
Epistaxis, Immediate post-injection reaction Epistaxis, Immediate post-injection reaction
Patient's nose immediately started bleeding heavily after administration lasting about 15 minut... Patient's nose immediately started bleeding heavily after administration lasting about 15 minutes. More
2868174 1.25 F GA 10/24/2025 DTAPIPV
FLUN3
 GLAXOSMITHKLINE BIOLOGICALS
MEDIMMUNE VACCINES, INC.
 3RT93
YF3413
No adverse event, Product administered to patient of inappropriate age; No adver... No adverse event, Product administered to patient of inappropriate age; No adverse event, Product administered to patient of inappropriate age More
My colleague administered vaccine to a patient who is 17 months and 3 days which is not age appropr... My colleague administered vaccine to a patient who is 17 months and 3 days which is not age appropriate. It happened on a very busy day, and she realized after administration. We followed up in person in office with parents and child is doing well, she has not experienced any adverse effect She has another follow up appointment coming up on 10/24/2025. She will be very careful in future to administer any vaccine. More
2868175 64 M TX 10/24/2025 FLU3
 SEQIRUS, INC.
 407256
No adverse event, Product administered to patient of inappropriate age No adverse event, Product administered to patient of inappropriate age
No adverse event reported but patient is under the minimum age of 65. No adverse event reported but patient is under the minimum age of 65.
2868176 69 F CT 10/24/2025 COVID19
 MODERNA
 8146670
Urticaria Urticaria
Patient reported massive red welt along with hives. Welt and hives went away over time without any t... Patient reported massive red welt along with hives. Welt and hives went away over time without any type of treatment. More
2868177 11 M MI 10/24/2025 FLU3
HPV9
MENB
MNQ
TDAP
 GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
NOVARTIS VACCINES AND DIAGNOSTICS
NOVARTIS VACCINES AND DIAGNOSTICS
GLAXOSMITHKLINE BIOLOGICALS
 2T543
Y018398
CD44A
9549B
PD324
Wrong product administered; Wrong product administered; Wrong product administer... Wrong product administered; Wrong product administered; Wrong product administered; Wrong product administered; Wrong product administered More
MenB was given instead of Menveo and provider requested we adminster Menveo before patient left. MenB was given instead of Menveo and provider requested we adminster Menveo before patient left.
2868178 57 F IN 10/24/2025 COVID19
 MODERNA
 3053669
Chills, Fatigue, Headache, Pain Chills, Fatigue, Headache, Pain
Around bedtime on 10/15/25: pt started experiencing headache, chills, body aches and fatigue. last i... Around bedtime on 10/15/25: pt started experiencing headache, chills, body aches and fatigue. last into 10/16/25. pt had severe headache in the night on 10/17/25 More
2868179 10 F MI 10/24/2025 FLU3
 SANOFI PASTEUR
 U8855DA
Product administered to patient of inappropriate age Product administered to patient of inappropriate age
none none
๐Ÿ“‹ Privacy Policy & Data Disclaimer